Colorectal Cancer Pipeline Report: Guide Features Descriptive Drug Profiles & Other Developmental Activities

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H1 2018, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

Pune, India – July 5, 2018 /MarketersMedia/ —

Colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools and weight loss with no known reason. Risk factors include smoking, heavy alcohol use, inflammatory bowel disease (IBD) and family history. Treatment includes surgery, radiation therapy and chemotherapy.

Report Source: https://www.themarketreports.com/report/colorectal-cancer-pipeline-review-h1-2018

Scope
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Colorectal Cancer (Oncology) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Colorectal Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Colorectal Cancer (Oncology)

Purchase this report at: https://www.themarketreports.com/report/buy-now/1206000

Reasons To Buy
• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Colorectal Cancer (Oncology).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Colorectal Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Got a question; ask us at: https://www.themarketreports.com/report/ask-your-query/1206000

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/colorectal-cancer-pipeline-report-guide-features-descriptive-drug-profiles-other-developmental-activities/372759

For more information, please visit https://www.themarketreports.com/report/colorectal-cancer-pipeline-review-h1-2018

Source: MarketersMedia

Release ID: 372759